GLP-1 agonists – of which Novo Nordisk’s Ozempic and Wegovy (semaglutide) and Eli Lilly’s Mounjaro (tirzepatide) are the most ...

Every earnings season has its share of outperformers, companies that report blowout quarters and raise their forecasts. The ...

These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...

Company behind weight loss drug Mounjaro, Lilly, has issued an official statement after British woman, Susan McGowan, died ...

The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...

The stock of Eli Lilly and Company LLY has declined 10.6% in a month ... These can pose strong competition to ...

The Mounjaro manufacturer, Eli Lilly, said patient safety was the company’s top priority. So, how worried should people be ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

Sahpra warns of falsified diabetes treatments Ozempic and Mounjaro sold online for weight loss, posing health risks.

The latest celebrity weight-loss drug to be given the nod in Hong Kong will be available in December, but experts cautioned ...

We recently published a list of 10 Best Stocks to Buy According to Billionaire Ken Fisher. In this article, we are going to ...